DEA Clarifies Direct Delivery of Prescribed Controlled Substances to Practitioners October 30, 2026 By Andrew J. Hull & Karla L. Palmer —

https://www.thefdalawblog.com/2026/10/dea-clarifies-direct-delivery-of-prescribed-controlled-substances-to-practitioners/?utm_source=rss&utm_medium=rss&utm_campaign=dea-clarifies-direct-delivery-of-prescribed-controlled-substances-to-practitioners On October 28th, DEA issued the guidance we anticipated and discussed over two years ago in our June 2024 blog post. The guidance explains when a DEA-registered pharmacy may deliver a prescribed controlled substance directly to a practitioner for administration to a patient, so long as the patient has executed a power of attorney (POA) permitting the practitioner to accept delivery of the substance on the patient’s behalf.